Relevant bibliographies by topics / Antigeni tumore associati / Books

Books on the topic 'Antigeni tumore associati'

To see the other types of publications on this topic, follow the link: Antigeni tumore associati.
Author: Grafiati
Published: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 20 books for your research on the topic 'Antigeni tumore associati.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

C, Ghosh Bimal, and Ghosh Luna, eds. Tumor markers and tumor-associated antigens. New York: McGraw-Hill, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gires, Olivier, and Barbara Seliger. Tumor-associated antigens: Identification, characterization, and clinical applications. Weinheim: Wiley-VCH, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chuang, Hong-Yang. Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-46848-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hamburger Symposium über Tumormarker. (6th 1991 Hamburg, Germany). Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis and therapy at the beginning of the Nineties: 6th Symposium on Tumor Markers, Hamburg 1991. München: W. Zuckschwerdt Verlag, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gires, Olivier, and Barbara Seliger, eds. Tumor‐Associated Antigens. Wiley, 2009. http://dx.doi.org/10.1002/9783527625970.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tumor-Associated Antigens: Identification, Characterization, and Clinical Applications. Wiley-VCH Verlag GmbH, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gires, Olivier, and Barbara Seliger. Tumor-Associated Antigens: Identification, Characterization, and Clinical Applications. Wiley & Sons, Incorporated, John, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

(Editor), Dirk Nagorsen, and F. M. Marincola (Editor), eds. Analyzing T Cell Responses: How to analyze cellular immune responses against tumor associated antigens. Springer, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Marincola, Francesco M., and Dirk Nagorsen. Analyzing T Cell Responses: How to Analyze Cellular Immune Responses Against Tumor Associated Antigens. Springer London, Limited, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Marincola, Francesco M., and Dirk Nagorsen. Analyzing T Cell Responses: How to Analyze Cellular Immune Responses Against Tumor Associated Antigens. Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Guo, Xiangqian, Jianying Zhang, Bilian Jin, and Qing Zhu, eds. Tumor-Associated Antigens and Their Autoantibodies: From Discovering to Clinical Utilization. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-797-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Alharbi, Yousef, Manish S. Patankar, and Rebecca J. Whelan. Antibody-Based Therapy for Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0006.

Full text
Abstract:
With their role in connecting disease-associated antigens to the cellular immune response, antibodies hold considerable promise as therapeutic agents. This chapter discusses three classes of therapeutic antibodies that have been developed for use in ovarian cancer therapy. The first includes antibodies selected against tumor-associated antigens such as MUC16/CA125, mesothelin, epithelial cell adhesion molecule, and folate receptor α‎. Antibodies in the second class target proteins such as CTLA-4 and PD1 that act as immune response checkpoint receptors. The third class of antibodies target secreted factors that promote tumor growth: targets in this class include vascular endothelial growth factor, cytokines, and chemokines. The development of each of these is described. The chapter also discusses the complications presented by soluble antigens, which serve to limit the applicability of antigens (such as MUC16/CA125) that are both cell-surface associated and circulating and the prospects for the combination of antibody-based immunotherapy and chemotherapy.
APA, Harvard, Vancouver, ISO, and other styles
13

Greten, H., and R. Klapdor. New Tumour Associated Antigens: Two Years Clinical Experience with Monoclonal Antibodies. Thieme Publishing Group, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Chuang, Hong-Yang. Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer. Springer, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Chuang, Hong-Yang. Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer. Springer Berlin / Heidelberg, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Chuang, Hong-Yang. Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

EBNA1 and EpsteinBarr Virus Associated Tumours Springerbriefs in Cancer Research. Springer-Verlag New York Inc., 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Hepatitis B Research Advances. Nova Science Pub Inc, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Abe, Hiroyuki, Amane Sasada, Shigeki Tabata, and Minako Abe. Heat Shock Protein Vaccine Therapy for Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0009.

Full text
Abstract:
Despite advances in chemotherapeutic regimens, ovarian cancer has a poor prognosis. Therefore important effective treatments are urgently needed. Many studies have reported that the immune system plays a critical role in disease progression and overall survival. One known effective immunotherapy is the dendritic cell (DC)-based vaccine pulsed with tumor-associated antigens. This chapter reports on a method of production of a novel DC-based vaccine. The key technologies are (a) monocyte collection without leukapheresis, (b) monocyte expansion, (c) production of dendritic cells, (d) multiple overlapping long peptides with heat shock protein 70, and (e) combination immunotherapy approach. The next generation of immunotherapy for ovarian cancer will be focused on combination approaches that simultaneously augment immunity while preventing local immune suppression. Possible combinations which might be useful to help patients with ovarian cancer are summarized in this chapter.
APA, Harvard, Vancouver, ISO, and other styles
20

Cooperberg, Matthew, and Peter Carroll. Prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0064.

Full text
Abstract:
Management of prostate cancer remains controversial, in large part because of its wide heterogeneity in terms of aggressiveness and prognosis. Early detection efforts based on prostate specific antigen (PSA) and aggressive treatment of high-risk cancers have yielded major improvements in mortality rates, but overtreatment of low-risk cancers—those unlikely to cause symptoms or threaten life if they were never detected—is associated with high rates of avoidable toxicity and cost. Prostate cancer can be effectively risk-stratified based on tools (e.g. nomograms, CAPRA score) integrating the PSA level, Gleason grade, clinical stage, and extent of biopsy tissue involvement. Most men with low-risk tumours are eligible for active surveillance, a programme of careful monitoring based on PSA and follow-up biopsies. Men with higher-risk cancers are best served with radical prostatectomy or radiation therapy.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Antigeni tumore associati' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography